PHARVARIS N V's ticker is PHVS and the CUSIP is N69605108. A total of 22 filers reported holding PHARVARIS N V in Q1 2023. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $691,674 | +33.8% | 33,142 | -2.9% | 1.10% | +192.1% |
| Q2 2023 | $516,910 | +88.0% | 34,142 | 0.0% | 0.38% | +86.2% |
| Q1 2023 | $275,014 | -28.4% | 34,142 | 0.0% | 0.20% | -31.9% |
| Q4 2022 | $384,098 | +46.6% | 34,142 | 0.0% | 0.30% | +48.3% |
| Q3 2022 | $262,000 | -65.3% | 34,142 | 0.0% | 0.20% | -61.9% |
| Q2 2022 | $755,000 | +22.0% | 34,142 | 0.0% | 0.53% | +108.3% |
| Q1 2022 | $619,000 | +26.1% | 34,142 | 0.0% | 0.25% | +109.1% |
| Q4 2021 | $491,000 | -92.4% | 34,142 | -90.6% | 0.12% | -94.0% |
| Q3 2021 | $6,456,000 | -4.8% | 364,142 | 0.0% | 2.01% | -24.8% |
| Q2 2021 | $6,784,000 | -63.5% | 364,142 | -45.2% | 2.67% | -51.1% |
| Q1 2021 | $18,583,000 | – | 664,142 | – | 5.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 3,743,450 | $78,125,802 | 43.39% |
| venBio Partners LLC | 4,264,672 | $89,003,705 | 25.24% |
| Bain Capital Life Sciences Investors, LLC | 4,784,674 | $99,856,146 | 11.17% |
| 5AM Venture Management, LLC | 587,600 | $12,263,212 | 3.53% |
| VR Adviser, LLC | 1,563,513 | $32,630,516 | 3.44% |
| Novo Holdings A/S | 1,329,325 | $27,743,013 | 2.05% |
| Cormorant Asset Management, LP | 1,361,460 | $28,413,670 | 1.66% |
| GENERAL ATLANTIC, L.P. | 4,406,252 | $91,958,479 | 1.42% |
| Foresite Capital Management V, LLC | 33,142 | $691,674 | 1.10% |
| Soleus Capital Management, L.P. | 343,975 | $7,178,758 | 0.66% |